-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on TELA Bio, Lowers Price Target to $7

Benzinga·03/21/2025 17:23:12
Listen to the news
Canaccord Genuity analyst Caitlin Cronin maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $12 to $7.